{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:53:36Z","timestamp":1781582016391,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2025405072"],"award-info":[{"award-number":["H2025405072"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Research Project of Hebei Education Department","award":["QN2023024"],"award-info":[{"award-number":["QN2023024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01936-7","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:16:30Z","timestamp":1781579790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DLEU2 promotes the migration and invasion of papillary thyroid carcinoma cells through the ELAVL1\/RCC2 axis"],"prefix":"10.1007","volume":"26","author":[{"given":"Suwei","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"10","key":"1936_CR1","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/cdd.2010.34","volume":"17","author":"P Beauchamp","year":"2010","unstructured":"Beauchamp P, Nassif C, Hillock S, van der Giessen K, von Roretz C, Jasmin BJ, Gallouzi IE (2010) The cleavage of HuR interferes with its transportin-2-mediated nuclear import and promotes muscle fiber formation. Cell Death Differ 17(10):1588\u20131599. https:\/\/doi.org\/10.1038\/cdd.2010.34","journal-title":"Cell Death Differ"},{"issue":"4","key":"1936_CR2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli MT, Viereck J, Thum T (2016) Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev 96(4):1297\u20131325. https:\/\/doi.org\/10.1152\/physrev.00041.2015","journal-title":"Physiol Rev"},{"key":"1936_CR3","doi-asserted-by":"publisher","unstructured":"Bridges MC, Daulagala AC, Kourtidis A (2021) LNCation: lncRNA localization and function. J Cell Biol 220(2). https:\/\/doi.org\/10.1083\/jcb.202009045","DOI":"10.1083\/jcb.202009045"},{"key":"1936_CR4","doi-asserted-by":"publisher","first-page":"939784","DOI":"10.3389\/fonc.2022.939784","volume":"12","author":"Z Cai","year":"2022","unstructured":"Cai Z, Xu H, Bai G, Hu H, Wang D, Li H, Wang Z (2022) ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators. Front Oncol 12:939784. https:\/\/doi.org\/10.3389\/fonc.2022.939784","journal-title":"Front Oncol"},{"issue":"1","key":"1936_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4081\/oncol.2021.525","volume":"15","author":"A Calderon-Aparicio","year":"2021","unstructured":"Calderon-Aparicio A, Bode AM (2021) Roles of regulator of chromosome condensation 2 in cancer: Beyond its regulatory function in cell cycle. Oncol Rev 15(1):525. https:\/\/doi.org\/10.4081\/oncol.2021.525","journal-title":"Oncol Rev"},{"issue":"27","key":"1936_CR6","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.7150\/jca.36430","volume":"10","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wu W, Huang Y, Xie L, Li Y, Chen H, Hu K (2019) RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT. J Cancer 10(27):6837\u20136847. https:\/\/doi.org\/10.7150\/jca.36430","journal-title":"J Cancer"},{"issue":"11","key":"1936_CR7","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1158\/1535-7163.Mct-19-0822","volume":"19","author":"R Dong","year":"2020","unstructured":"Dong R, Chen P, Polireddy K, Wu X, Wang T, Ramesh R, Chen Q (2020) An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells. Mol Cancer Ther 19(11):2267\u20132277. https:\/\/doi.org\/10.1158\/1535-7163.Mct-19-0822","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"1936_CR8","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1158\/0008-5472.Can-23-0972","volume":"83","author":"JM Finan","year":"2023","unstructured":"Finan JM, Sutton TL, Dixon DA, Brody JR (2023) Targeting the RNA-Binding Protein HuR in Cancer. Cancer Res 83(21):3507\u20133516. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0972","journal-title":"Cancer Res"},{"key":"1936_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fmolb.2017.00071","volume":"4","author":"SM Garc\u00eda-Mauri\u00f1o","year":"2017","unstructured":"Garc\u00eda-Mauri\u00f1o SM, Rivero-Rodr\u00edguez F, Vel\u00e1zquez-Cruz A, Hern\u00e1ndez-Vellisca M, D\u00edaz-Quintana A, De la Rosa MA, D\u00edaz-Moreno I (2017) RNA Binding Protein Regulation and Cross-Talk in the Control of AU-rich mRNA Fate. Front Mol Biosci 4:71. https:\/\/doi.org\/10.3389\/fmolb.2017.00071","journal-title":"Front Mol Biosci"},{"issue":"5","key":"1936_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1210\/endrev\/bnad013","volume":"44","author":"ML Gild","year":"2023","unstructured":"Gild ML, Clifton-Bligh RJ, Wirth LJ, Robinson BG (2023) Medullary Thyroid Cancer: Updates and Challenges. Endocr Rev 44(5):934\u2013946. https:\/\/doi.org\/10.1210\/endrev\/bnad013","journal-title":"Endocr Rev"},{"key":"1936_CR11","doi-asserted-by":"publisher","unstructured":"Grammatikakis I, Abdelmohsen K, Gorospe M (2017) Posttranslational control of HuR function. Wiley Interdiscip Rev RNA 8(1). https:\/\/doi.org\/10.1002\/wrna.1372","DOI":"10.1002\/wrna.1372"},{"issue":"1","key":"1936_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12935-021-02074-9","volume":"21","author":"S Han","year":"2021","unstructured":"Han S, Qi Y, Xu Y, Wang M, Wang J, Wang J, Liu X (2021) lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p. Cancer Cell Int 21(1):376. https:\/\/doi.org\/10.1186\/s12935-021-02074-9","journal-title":"Cancer Cell Int"},{"issue":"20","key":"1936_CR13","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1007\/s00018-008-8252-6","volume":"65","author":"MN Hinman","year":"2008","unstructured":"Hinman MN, Lou H (2008) Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65(20):3168\u20133181. https:\/\/doi.org\/10.1007\/s00018-008-8252-6","journal-title":"Cell Mol Life Sci"},{"key":"1936_CR14","doi-asserted-by":"publisher","first-page":"103519","DOI":"10.1016\/j.redox.2025.103519","volume":"80","author":"C Hu","year":"2025","unstructured":"Hu C, Xu J, Zhang Y, Zhang R, Pan S, Chen J, Cheng X (2025) Inhibition of glutathione peroxidase 4 suppresses gastric cancer peritoneal metastasis via regulation of RCC2 homeostasis. Redox Biol 80:103519. https:\/\/doi.org\/10.1016\/j.redox.2025.103519","journal-title":"Redox Biol"},{"key":"1936_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha D, Nilubol N, Boufraqech M (2020) New Therapies for Advanced Thyroid Cancer. Front Endocrinol (Lausanne) 11:82. https:\/\/doi.org\/10.3389\/fendo.2020.00082","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1936_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3727\/096504016x14549667334007","volume":"23","author":"J Li","year":"2016","unstructured":"Li J, Meng H, Bai Y, Wang K (2016) Regulation of lncRNA and Its Role in Cancer Metastasis. Oncol Res 23(5):205\u2013217. https:\/\/doi.org\/10.3727\/096504016x14549667334007","journal-title":"Oncol Res"},{"key":"1936_CR17","doi-asserted-by":"publisher","first-page":"102312","DOI":"10.1016\/j.redox.2022.102312","volume":"52","author":"Z Lin","year":"2022","unstructured":"Lin Z, Song J, Gao Y, Huang S, Dou R, Zhong P, Xiong B (2022) Hypoxia-induced HIF-1\u03b1\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer. Redox Biol 52:102312. https:\/\/doi.org\/10.1016\/j.redox.2022.102312","journal-title":"Redox Biol"},{"issue":"4","key":"1936_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3892\/br.2021.1461","volume":"15","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang Y, Chen C, Li Y (2021) lncRNA HIF1A-AS2: A potential oncogene in human cancers (Review). Biomed Rep 15(4):85. https:\/\/doi.org\/10.3892\/br.2021.1461","journal-title":"Biomed Rep"},{"issue":"7","key":"1936_CR19","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s12094-023-03109-5","volume":"25","author":"Q Ma","year":"2023","unstructured":"Ma Q, Lu Q, Lei X, Zhao J, Sun W, Huang D, Xu Q (2023) Relationship between HuR and tumor drug resistance. Clin Transl Oncol 25(7):1999\u20132014. https:\/\/doi.org\/10.1007\/s12094-023-03109-5","journal-title":"Clin Transl Oncol"},{"key":"1936_CR20","doi-asserted-by":"publisher","first-page":"114442","DOI":"10.1016\/j.addr.2022.114442","volume":"188","author":"M Majumder","year":"2022","unstructured":"Majumder M, Chakraborty P, Mohan S, Mehrotra S, Palanisamy V (2022) HuR as a molecular target for cancer therapeutics and immune-related disorders. Adv Drug Deliv Rev 188:114442. https:\/\/doi.org\/10.1016\/j.addr.2022.114442","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1936_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Siegel RL (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731","journal-title":"CA Cancer J Clin"},{"key":"1936_CR22","doi-asserted-by":"publisher","first-page":"107390","DOI":"10.1016\/j.pharmthera.2019.07.001","volume":"203","author":"S Mohibi","year":"2019","unstructured":"Mohibi S, Chen X, Zhang J (2019) Cancer the\u2019RBP\u2019eutics-RNA-binding proteins as therapeutic targets for cancer. Pharmacol Ther 203:107390. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.07.001","journal-title":"Pharmacol Ther"},{"issue":"18","key":"1936_CR23","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1158\/1078-0432.Ccr-16-2909","volume":"23","author":"B Pang","year":"2017","unstructured":"Pang B, Wu N, Guan R, Pang L, Li X, Li S, Jin Y (2017) Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition. Clin Cancer Res 23(18):5598\u20135610. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-2909","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1936_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, Zheng L (2020) RNA-binding proteins in tumor progression. J Hematol Oncol 13(1):90. https:\/\/doi.org\/10.1186\/s13045-020-00927-w","journal-title":"J Hematol Oncol"},{"issue":"Pt 3","key":"1936_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.semcancer.2022.05.013","volume":"86","author":"H Shaath","year":"2022","unstructured":"Shaath H, Vishnubalaji R, Elango R, Kardousha A, Islam Z, Qureshi R, Alajez NM (2022) Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches. Sem Cancer Biol 86(Pt 3):325\u2013345. https:\/\/doi.org\/10.1016\/j.semcancer.2022.05.013","journal-title":"Sem Cancer Biol"},{"issue":"1","key":"1936_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13062-023-00439-w","volume":"18","author":"S Wang","year":"2023","unstructured":"Wang S, Lei Z, Liu W, Xiong J, Shi Y, Yang L, Zhang B (2023) RCC2 promotes prostate cancer cell proliferation and migration through Hh\/GLI1 signaling pathway and cancer stem-like cells. Biol Direct 18(1):80. https:\/\/doi.org\/10.1186\/s13062-023-00439-w","journal-title":"Biol Direct"},{"issue":"5","key":"1936_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2174\/1568009618666181031145953","volume":"19","author":"M Wu","year":"2019","unstructured":"Wu M, Tong CWS, Yan W, To KKW, Cho WCS (2019) The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy. Curr Cancer Drug Targets 19(5):382\u2013399. https:\/\/doi.org\/10.2174\/1568009618666181031145953","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"1936_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41388-021-02099-4","volume":"41","author":"Q Wu","year":"2022","unstructured":"Wu Q, Liu F, Ge M, Laster KV, Wei L, Du R, Liu K (2022) BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression. Oncogene 41(3):347\u2013360. https:\/\/doi.org\/10.1038\/s41388-021-02099-4","journal-title":"Oncogene"},{"key":"1936_CR29","doi-asserted-by":"publisher","first-page":"111158","DOI":"10.1016\/j.biopha.2020.111158","volume":"134","author":"C Xing","year":"2021","unstructured":"Xing C, Sun SG, Yue ZQ, Bai F (2021) Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother 134:111158. https:\/\/doi.org\/10.1016\/j.biopha.2020.111158","journal-title":"Biomed Pharmacother"},{"key":"1936_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.biopha.2018.03.098","volume":"102","author":"W Xu","year":"2018","unstructured":"Xu W, Chen C, Xu R, Li Y, Hu R, Li Z, Zhu X (2018) Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents. Biomed Pharmacother 102:587\u2013593. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.098","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1936_CR30","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/cas.13987","volume":"110","author":"B Xu","year":"2019","unstructured":"Xu B, Gong X, Zi L, Li G, Dong S, Chen X, Li Y (2019) Silencing of DLEU2 suppresses pancreatic cancer cell proliferation and invasion by upregulating microRNA-455. Cancer Sci 110(5):1676\u20131685. https:\/\/doi.org\/10.1111\/cas.13987","journal-title":"Cancer Sci"},{"issue":"2","key":"1936_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cac2.12254","volume":"42","author":"ZT Yao","year":"2022","unstructured":"Yao ZT, Yang YM, Sun MM, He Y, Liao L, Chen KS, Li B (2022) New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. Cancer Commun (Lond) 42(2):117\u2013140. https:\/\/doi.org\/10.1002\/cac2.12254","journal-title":"Cancer Commun (Lond)"},{"issue":"8","key":"1936_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2174\/156652408786733748","volume":"8","author":"J Zhang","year":"2008","unstructured":"Zhang J, Chen X (2008) Posttranscriptional regulation of p53 and its targets by RNA-binding proteins. Curr Mol Med 8(8):845\u2013849. https:\/\/doi.org\/10.2174\/156652408786733748","journal-title":"Curr Mol Med"},{"key":"1936_CR35","doi-asserted-by":"publisher","unstructured":"Zhang N, Wen K (2024) The role of lncRNA binding to RNA\u2013binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review). Oncol Rep 52(5). https:\/\/doi.org\/10.3892\/or.2024.8801","DOI":"10.3892\/or.2024.8801"},{"issue":"2","key":"1936_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","volume":"54","author":"N Zhang","year":"2022","unstructured":"Zhang N, Shen Y, Li H, Chen Y, Zhang P, Lou S, Deng J (2022) The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Exp Mol Med 54(2):194\u2013205. https:\/\/doi.org\/10.1038\/s12276-022-00735-x","journal-title":"Exp Mol Med"},{"issue":"3","key":"1936_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3760\/cma.j.cn112152-20240119-00035","volume":"46","author":"RS Zheng","year":"2024","unstructured":"Zheng RS, Chen R, Han BF, Wang SM, Li L, Sun KX, He J (2024) Cancer incidence and mortality in China, 2022. Zhonghua Zhong Liu Za Zhi 46(3):221\u2013231. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20240119-00035","journal-title":"Zhonghua Zhong Liu Za Zhi"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01936-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01936-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01936-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:16:36Z","timestamp":1781579796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01936-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1936"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01936-7","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}